Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 9.50
0.00 (0.00%)
Mar 9, 2026, 4:25 PM CET
Lytix Biopharma AS Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
730.55M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Circio Holding ASA | 123.00K |
| Nykode Therapeutics AS | 4.57M |
| ArcticZymes Technologies ASA | 118.21M |
| Zelluna ASA | 53.00K |
| SoftOx Solutions AS | 13.59M |
| Arctic Bioscience AS | 45.90M |
| Aqua Bio Technology ASA | 101.51M |
| PCI Biotech Holding ASA | 4.69M |